In each experiment tumour slices from one or more animals were pooled and 750 mg. slices were incubated with 3-75 ml. Krebs Ringer phosphate buffer containing either 1-875 mg. acetate-i-C14 or 2-5 mg. pyruvate-2-C14 per flask. The data on C02, cholesterol and fatty acids are expressed per 1 g.of fresh tumour tissue. The counts/min. of the proteins are given as " infinitely thick layers on 1 square centimetre area. Tables I, II and III. In all the tumours studied pyruvate appears to be more readily oxidized via the Krebs cycle than acetate, since the total amount of C14 present in the carbon dioxide following incubation with pyruvate-2-C14 always exceeded the total activity contained in carbon dioxide when the equivalent amount of acetate-i-C14 was used. The sarcomatoid types oxidize pyruvate to a much greater extent than they do acetate. The least prominent difference between the two substrates, in this respect, exists in the case of the two hepatomas. The incorporation of tracer from pyruvate into tumour proteins also exceeds that from acetate in all of the six tumours investigated. Again in the hepatomas the preference of pyruvate utilization for protein synthesis seems less marked than in the other tumours. The differences which exist between the hepatomas, on one hand, and the remaining tumours on the other, are most clearly demonstrated by the data representing the lipogenesis.
In both the transplanted and the spontaneous hepatomas acetate incorporation into fatty acids equals or even surpasses pyruvate incorporation, whereas the opposite is true for the other four tumours.
As a whole, radioacetate is slightly superior to radiopyruvate in the extent to which the C14 of the C2 fragment is incorporated into the hepatoma cholesterol.
Although the absolute rates of pyruvate and acetate utilization differ significantly, the ratio between pyruvate and acetate incorporation into cholesterol is approximately constant for both hepatomas.
The two sarcomatoid tumours are characterized by a high preponderance of pyruvate incorporation over that of acetate into cholesterol.
DISCUSSION.
The question arises as to what may be the regulatory mechanisms which govern the direction of flow of the two-carbon fragments to the diverse metabolic products in the neoplastic tissues and to what extent these mechanisms may be characteristic for a group of tumours.
Acetate seems to be superior to pyruvate as a carbon source for the formation of higher fatty acids in liver slices (Bloch, 1952 ; Anker, 1948) . This is primarily because pyruvate, in contrast to acetate, is converted for the greater part to glycogen and lactic acid. Except for the hepatomas, practically no glycogen storage occurs in the other tumours and hence the competing enzymes, distracting pyruvate from this alternative metabolic pathway, are not engaged. The rates to which acetate-i-C14 or pyruvate-2-C14, which both yield 1-C'4-acetyl-coenzyme A, are incorporated into the substances isolated in this investigation depends among other things on the relative effective concentrations of competing enzymes and coenzymes. The potential concentration of coenzyme A (CoA) was determined in five of the six tumours (Emmelot and Bosch, 1955a, 1955b) . The results showed that the content of this enzyme paralleled roughly the synthetic abilities of the tumours, although it was demonstrated that, in general, the level of CoA need not be the rate limiting factor in biosynthesis.
Preliminary experiments seem to indicate that the alternative reaction:
pyruvate --lactate may play some role, since a greater amount of lactate is produced by the hepatomas (1.0-1 2 mg. lactic acid per g. wet weight of tumour slices from 3 mg. pyruvate in 1 hour) under aerobic conditions than by the four remaining tumours (0.7-0.8 mg. lactic acid).
Another important feature is the energy supply necessary for the initial activation reaction of acetate to acetyl-CoA, in contrast with the formation of acetyl-CoA starting from pyruvate which needs no adenosine triphosphate. This may have its bearing on the metabolic processes in the different tumours. There is ample evidence from this and the preceding investigation, that the sarcomatoid ovarian tumours oxidize acetic acid at a lower rate than the other tumours studied, whereas a pronounced preference of the sarcomatoid tumours for pyruvate utilization in all the metabolic reactions was noted.
At the moment there seems no simple answer to the question why the tumours display such quantitative differences in metabolic behaviour, as expressed by the preferential utilization of acetate or pyruvate for the synthesis of certain cell constituents. In Table IV the ratio between the incorporation of tracer from pyruvate and acetate for the various compounds, isolated from the six tumours, are given. In considering the data from this table, the three tumour groups may be listed with increasing ability to utilize pyruvate relative to acetate in the order, hepatomas, ovarian tumours of the granulosa cell type, and ovarian tumours of the sarcomatoid type.
Despite individual variations in the ratios of C14 incorporation and the limited numrber of tumours studied, it may appear from this that regulatory mechanisms are operative which control the rate of flow of the carbon intermediates derived from pyruvate, with respect to those derived from acetate, in a relatively similar manner in those tumours which belong to the same group. It must be emphasized that the tumours chosen in the present investigationtwo in each group-differ significantly in both their origin and growth rate. In the group of hepatomas, spontaneous and transplanted tumours were studied. The transplanted hepatomas usually took 2-2-5 months per generation, Tumour 5441 of the granulosa cell type 1 month and Tumour 19957 4-5 months. The two sarcomatoid types, on the other hand have a fast growth-rate (3 weeks). Hence the biochemical features found are not simply due to the rate of tumour growth per se.
The scope of this work does not permit us to state whether similar biochemical characteristics can be ascribed to other tumours but it is hoped to study this as soon as possible. SUMMARY. 1. The relative rates of pyruvate and acetate incorporation into carbon dioxide, protein-bound amino acids, cholesterol and higher fatty acids were studied in three different groups consisting of two tumours each.
2. The ratio between pyruvate and acetate incorporation appeared to furnish a fair means of evaluating differences in metabolic behaviour and of classifying the six tumours studied into three groups.
3. The tumours could be listed with an increasing ability to utilize pyruvate relative to acetate in the order: hepatomas, ovarian tumours of the granulosa cell type, and ovarian tumours of the sarcomatoid type.
